Climb Bio
IPOInspired Medicines for Immune-Mediated Diseases
Public · Wellesley Hills, United States · $170.0M raised
- Headquarters
- Wellesley Hills, Massachusetts
- Business Model
- B2B
- Website
- climbbio.com
- Total Funding
- $170.0M
- Last Round
- $110.0M Private EquityApr 2026
- Rounds
- 2
- Type
- Public
About
Clinical-stage biotechnology company developing disease-modifying medicines for immune-mediated diseases.
Summary
Climb Bio is a Biotech company based in Wellesley Hills, United States. It has raised $170.0M in total across 2 rounds, most recently a $110.0M Private Equity round in Apr 2026. Investors include Adage Capital, RA Capital Management and Intermediate Capital Group.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Apr 2026
Sign up to see all 2 rounds
Series B through Private Equity — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/climb-bio"><img src="https://indexed.vc/api/badge/company/climb-bio" alt="Climb Bio on Indexed.vc" width="260" height="76" /></a>